Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

27.52
BATS BZX Real-Time Price
As of 11:18am ET
 -0.27 / -0.97%
Today’s Change
16.64
Today|||52-Week Range
42.49
-22.81%
Year-to-Date
Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November
Dec 05 / MotleyFool.com - Paid Partner Content
5 Biotech Stocks George Soros Is Buying
Nov 22 / MotleyFool.com - Paid Partner Content
3 Biotechs With Save-the-Date Catalysts on Tap
Nov 29 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close27.79
Today’s open27.82
Day’s range27.44 - 27.83
Volume9,439
Average volume (3 months)2,343,354
Market cap$3.4B
Dividend yield--
Data as of 11:18am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-43.19%
Earnings growth (next 5 years)+16.76%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book14.18

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.02-0.10%
CBPOChina Biologic Produ...+0.90+0.78%
ENDPEndo International P...-0.36-2.27%
RAREUltragenyx Pharmaceu...-1.69-2.20%
Data as of 11:18am ET, 12/06/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs